MacroGenics Completes Sale of GMP Manufacturing Operations to Bora Pharmaceuticals
MacroGenics completed the sale of its GMP manufacturing operations to Bora Pharmaceuticals for $122.5 million in upfront cash. The transaction includes the transfer of facilities in Rockville and Frederick, Maryland, and approximately 140 employees to Bora, which will now handle manufacturing for MacroGenics under a new supply agreement.
Key figures
- Deal Value Usd
- 122500000
- Employees transferred
- 140
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.